Cornerstone Capital Management Holdings’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$821K Sell
25,839
-67,600
-72% -$2.32M 0.01% 936
2017
Q3
$3.5M Sell
93,439
-100
-0.1% -$3.4K 0.03% 552
2017
Q2
$2.92M Sell
93,539
-49,000
-34% -$1.42M 0.02% 609
2017
Q1
$3.51M Sell
142,539
-21,250
-13% -$499K 0.03% 567
2016
Q4
$4.15M Buy
163,789
+13,200
+9% +$293K 0.03% 530
2016
Q3
$2.99M Buy
150,589
+41,600
+38% +$727K 0.02% 625
2016
Q2
$1.55M Buy
108,989
+10,000
+10% +$153K 0.01% 793
2016
Q1
$1.54M Buy
98,989
+34,700
+54% +$498K 0.01% 818
2015
Q4
$1.11M Buy
64,289
+49,589
+337% +$718K 0.01% 869
2015
Q3
$179K Buy
+14,700
New +$189K ﹤0.01% 1236

Other funds holding LMAT

Cornerstone Capital Management Holdings's LMAT Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its LeMaitre Vascular (LMAT) stake by 72% in Q4 2017, selling an estimated $2.32M and leaving 25,839 shares worth $821K. The position accounts for 0.01% of the portfolio, ranked #936.

Cornerstone Capital Management Holdings first reported a position in LMAT in Q3 2015 and has held it in 10 quarters since. The position peaked at $4.15M in Q4 2016. 142 funds tracked by Wall St. Rank hold LMAT as of Q4 2017.

  • Cornerstone Capital Management Holdings held 25,839 shares of LeMaitre Vascular worth $821K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 67,600 LeMaitre Vascular shares in Q4 2017, an estimated $2.32M.
  • LeMaitre Vascular made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #936 holding.
  • Cornerstone Capital Management Holdings first reported a position in LeMaitre Vascular in Q3 2015 and has held it in 10 quarters since.
  • Cornerstone Capital Management Holdings's LeMaitre Vascular position peaked at $4.15M in Q4 2016.
  • 142 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.